Premium
Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A 2 and prostacyclin in plasma
Author(s) -
Smith Anthony J.,
Walters William A.,
Buckley Nicholas A.,
Gallagher Lorraine,
Mason Anne,
Mcpherson Jean
Publication year - 1995
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1995.tb10879.x
Subject(s) - medicine , prostacyclin , blood pressure , eclampsia , pregnancy , thromboxane b2 , thromboxane a2 , thromboxane , venous blood , gestation , cardiology , endocrinology , obstetrics , platelet , genetics , biology
Objective By combining serial measurements of the circulating concentrations of thromboxane A, and prostacyclin with measurements of venous distensibility (taken during the pregnancies of both normal women and those with pregnancy induced hypertension or pre‐eclampsia), to test the following hypotheses: 1. that changes in the venous plasma ratio of thromboxane (TXB 2 ) and 6‐keto‐PGF1α would correlate with changes in the blood pressure of women developing and recovering from pregnancy induced hypertension or pre‐eclampsia and 2. that changes in venous distensibility would correlate with changes in arterial blood pressure in pregnancy induced hypertension or pre‐eclampsia. Design Prospective, longitudinal cohort study. Setting John Hunter Hospital clinic, Newcastle, Australia. Subjects One hundred and sixty primiparous women, recruited when presenting for their first routine antenatal visit, were investigated at, or close to, 19, 28 and 37 weeks of gestation; a subgroup was also studied in the postnatal period. The measurements of the patients who developed pregnancy induced hypertension or pre‐eclampsia were compared with those of controls selected from the cohort. Main outcome measures Serial measurements of the circulating concentrations of the stable metabolites of thromboxane A 2 and prostacyclin (TXB 2 and 6‐keto‐PGFlα, respectively), venous distensibility and immediate (no rest) and resting (for at least 30 min) blood pressures. Results There was no significant difference between the subject and control groups at any time during or after the pregnancy in the concentrations of prostaglandin metabolites, their ratio or venous distensibility. In contrast, there was a significant difference between the groups at 19 weeks for immediate and resting readings of diastolic pressure (6 mmHg (95 % CI 1.5 to 10.5) and 4 mmHg (95% CI 0.1 to 7.9), respectively). These differences increased through the pregnancy but mean postnatal readings for the groups were almost identical suggesting that the subjects were not intrinsically hypertensive compared with controls. Blood pressures for the subject group, both immediate and resting, were significantly different from the 19 week readings at 28 weeks (diastolic) and at 37 weeks (systolic and diastolic). The only significant change from first readings among controls was in postnatal systolic pressure which was significantly higher than 19 week values, probably reflecting the vasodilatation, with accompanying hypotension, of early, normal pregnancy. This difference was not observed in those who subsequently developed pregnancy induced hypertension or pre‐eclampsia. Conclusions Our study was unable to demonstrate differences in circulating metabolites or venous distensibility between normotensive women and those with pregnancy induced hypertension or pre‐eclampsia. If pregnancy induced hypertension or pre‐eclampsia in humans represents not so much the presence of abnormal constrictor influences as a process initiated by failure of normal vasodilatation in early pregnancy, studies carried out later may detect mainly adaptive and secondary changes.